by Stacey Johnson | Sep 24, 2021
Let’s play a game. If you could choose, what would be your superpower? Invisibility is a popular one, as are super strength, the ability to read minds, and time travel (but we know that messing with time can be dangerous). This list of the best superpowers of all time...
by Tara Fernandez | Aug 25, 2021
The last few decades have seen a dramatic leap in life expectancies across developed countries—people are living longer than ever before, and the age of the centenarian could soon be upon us. For example, in the ‘70s Canadians lived an average of 72.7 years. Today,...
by Tara Fernandez | Jul 7, 2021
In early 2021, a young boy in Barcelona was the first to receive Pfizer’s investigational gene therapy for Duchenne muscular dystrophy (DMD). This was part of a global Phase 3 human trial to test Pfizer’s lead candidate, PF-06939926, in a cohort of 99 patients with...
by Lyla El-Fayomi | Jun 30, 2021
“Regenerative medicine news under the microscope” is a new monthly feature highlighting big stories in stem cell research. I will sample the latest and greatest findings in recent press and package them into a single post. This month was packed with interesting...
by Stacey Johnson | Jun 25, 2021
Back in November 2020, California voters approved Proposition 14. That means US$5.5B is being directed to the California Institute for Regenerative Medicine (CIRM) to support promising cell and gene therapy research so the organization can continue the important work...
by Stacey Johnson | May 7, 2021
The incredible, non-stop growth of the global cell and gene therapy market – valued at ~$12 billion by 2025 – means that talent is in high demand. (That estimate does not include tissue engineering, but it still seems low.) While seasoned professionals and those with...
Comments